logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
E

Eric Van Cutsem

university hospitals leuven

174H-index
1.8KPaper Count
17.3WCitation Count
Published Papers 510
Publication Date
logo
Multi-omic biomarkers of neoadjuvant treatment response in rectal cancer: A narrative review
errEuropean Journal of Surgical Oncology
IF2.9
err2026-06-03
err0
PREAI
errPieter Maerten; Albert Wolthuis; André D’Hoore; Gabriele Bislenghi; Gert De Hertogh; Xavier Sagaert; Raphaëla Dresen; Valérie Broeckhoven; Gertjan Rasschaert; Sabine Tejpar; Filip Van Herpe; Eric Van Cutsem; Jeroen Dekervel; Karin Haustermans
errShare
errSave
Young onset rectal cancer (YORC): a descriptive tertiary center analysis
errEuropean Journal of Surgical Oncology
IF2.9
err2026-06-03
err0
PREAI
errCédric Schraepen; Gertjan Rasschaert; Pieter Maerten; Gabriele Bislenghi; Gert De Hertogh; Lynn Debrun; Raphaëla Dresen; Philippe Leclercq; Xavier Sagaert; Sabine Tejpar; Filip Van Herpe; Jeroen Dekervel; Karin Haustermans; Eric Van Cutsem; Ellen Coeckelberghs; André D’Hoore; Albert Wolthuis
errShare
errSave
CA19-9 as a Dynamic Biomarker for Continuous Monitoring of Therapeutic Efficacy in Pancreatic Adenocarcinoma
errCancers
IF4.4
err2026-03-04
err0
errOAAI
errLuigi Brancato; Damar Osok; Laurent Van den Bossche; Eric Van Cutsem; Susan E. Bates; Johan Van den Bossche; Johannes Bogers
errShare
errSave
Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer
errNature Communications
IF15.7
err2025-10-06
err0
errOAAI
errMing Lei; Michael J. Overman; Jin Yao; Thierry André; Sara Lonardi; Heinz-Josef Lenz; Massimo Aglietta; Fabio Gelsomino; Ray McDermott; Ka Yeung Mark Wong; Michael A. Morse; Eric Van Cutsem; Alain Hendlisz; Dana B. Cardin; Bart Neyns; Andrew Hill; Anuradha Krishnamurthy; Franklin Chen; Samith Kochuparambil; Robert R. Jenq; Sandzhar Abdullaev; Beilei He; Ruslan Novosiadly; Scott Kopetz
errShare
errSave
Chronological survival improvement over time with oxaliplatin-based chemotherapy plus targeted agents in metastatic colorectal cancer: an ARCAD database study
errEuropean Journal of Cancer
IF7.1
err2025-10-02
err0
errOAAI
errKazumasa Yamamoto; Hideaki Bando; Toshihiro Misumi; Tomomi Nishikawa; Masashi Wakabayashi; Kentaro Yamazaki; Yoshihiko Maehara; Eiji Oki; Leonard B Saltz; Jean-Yves Douillard; Cornelis JA Punt; Miriam Koopman; Eric Van Cutsem; Carsten Bokemeyer; Alan P Venook; Volker Heinemann; Chiara Cremolini; J. Randolph Hecht; Hans-Joachim Schmoll; Goro Nakayama; Heinz-Josef Lenz; Thierry Andre; Qian Shi; Aimery de Gramont; Kohei Shitara; Takayuki Yoshino
errShare
errSave
Impact of trifluridine/tipiracil plus bevacizumab on tumor shrinkage and depth of response in refractory metastatic colorectal cancer: analysis of the SUNLIGHT trial
errEuropean Journal of Cancer
IF7.1
err2025-07-12
err0
errOAAI
errJulien Taieb; Dominik P. Modest; Marwan Fakih; Fortunato Ciardiello; Eric Van Cutsem; Elena Elez; Cristina Gravalos; Arinilda Campos Bragagnoli; Valentine Barboux; Lucas Roby; Nadia Amellal; Gerald W. Prager
errShare
errSave
A plain language summary of the molecular changes in the tumors of people with BRAF V600E-mutant colorectal cancer in the BEACON study
errFUTURE ONCOLOGY
IF2.6
err2025-05-09
err0
errOAAI
errKopetz, Scott; Murphy, Danielle A.; Pu, Jie; Ciardiello, Fortunato; Desai, Jayesh; Van Cutsem, Eric; Wasan, Harpreet Singh; Yoshino, Takayuki; Saffari, Hedieh; Zhang, Xiaosong; Hamilton, Phineas; Xie, Tao; Yaeger, Rona; Tabernero, Josep
errShare
errSave
First-Line Tislelizumab Plus Chemotherapy for Esophageal Squamous Cell Carcinoma with Programmed Death-Ligand 1 Expression ≥ 1%: A Retrospective Analysis of RATIONALE-306
errADVANCES IN THERAPY
IF4
err2025-03-01
err0
errOAAI
errXu, Jianming; Kato, Ken; Hubner, Richard; Park, Sook Ryun; Kojima, Takashi; Ishihara, Ryu; Wyrwicz, Lucjan; Van Cutsem, Eric; Jimenez-Fonseca, Paula; Wu, Hongqian; Wang, Lei; Yan, Sebastian; Shi, Jingwen; Kadva, Alysha; Yoon, Harry H.
errShare
errSave
Pooled safety analysis of two phase 3 studies investigating trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer
errFRONTIERS IN ONCOLOGY
IF3.3
err2025-01-16
err1
errOAAI
errTaieb, Julien; Fakih, Marwan; Liposits, Gabor; Prager, Gerald W.; Van Cutsem, Eric; Ciardiello, Fortunato; Amellal, Nadia; Calleja, Elizabeth; Liu, Mei; Roby, Lucas; Tabernero, Josep; Andre, Thierry
errShare
errSave
MOUNTAINEER-03 phase III study design: first-line mFOLFOX6+tucatinib plus trastuzumab for HER2+metastatic colorectal cancer
errFUTURE ONCOLOGY
IF2.6
err2024-12-26
err1
errOAAI
errStrickler, John H.; Bekaii-Saab, Tanios; Cercek, Andrea; Heinemann, Volker; Nakamura, Yoshiaki; Raghav, Kanwal; Siena, Salvatore; Tabernero, Josep; Van Cutsem, Eric; Yoshino, Takayuki; Ramos, Jorge; Guan, Xuesong; Andre, Thierry
errShare
errSave
Organ Preservation After Immune Checkpoint Inhibition for Locally Advanced Rectal Cancer
errClinical Colorectal Cancer
IF3.2
err2024-12-15
err0
PREAI
errCharlotte Claeys; Antoon Billiet; Karin Haustermans; Albert Wolthuis; Gabriele Bislenghi; André D'Hoore; Raphaëla Dresen; Gertjan Rasschaert; Eric Van Cutsem; Filip Van Herpe; Jeroen Dekervel
errShare
errSave
Impact of Treatment With Trifluridine/Tipiracil in Combination With Bevacizumab on Health-Related Quality of Life and Performance Status in Refractory Metastatic Colorectal Cancer: An Analysis of the Phase III SUNLIGHT Trial
errClinical Colorectal Cancer
IF3.2
err2024-12-11
err0
errOAAI
errJulien Taieb; Marwan Fakih; Josep Tabernero; Fortunato Ciardiello; Eric Van Cutsem; Gemma Soler; Elizabeth Calleja; Valentine Barboux; Lucas Roby; Nadia Amellal; Gerald W. Prager
errShare
errSave
Nivolumab plus Ipilimumab in Microsatellite-Instability-High Metastatic Colorectal Cancer
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2024-11-28
err1
PREAI
errAndre, Thierry; Elez, Elena; Van Cutsem, Eric; Jensen, Lars Henrik; Bennouna, Jaafar; Mendez, Guillermo; Schenker, Michael; de la Fouchardiere, Christelle; Limon, Maria Luisa; Yoshino, Takayuki; Li, Jin; Lenz, Heinz-Josef; Manzano Mozo, Jose Luis; Tortora, Giampaolo; Garcia-Carbonero, Rocio; Dahan, Laetitia; Chalabi, Myriam; Joshi, Rohit; Goekkurt, Eray; Braghiroli, Maria Ignez; Cil, Timucin; Cela, Elvis; Chen, Tian; Lei, Ming; Dixon, Matthew; Abdullaev, Sandzhar; Lonardi, Sara
errShare
errSave
SUNLAND: a randomized, double-blinded phase II GERCOR trial of sunitinib versus placebo and lanreotide in patients with advanced progressive midgut neuroendocrine tumors
errTHERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
err2024-11-19
err0
errOAAI
errHammel, Pascal; Smith, Denis; Afchain, Pauline; Dominguez-Tinajero, Sophie; Seitz, Jean-Francois; Lievre, Astrid; Van Cutsem, Eric; Assenat, Eric; Di Fiore, Frederic; Peeters, Marc; Sobhani, Iradj; Raymond, Eric; Charton, Emilie; Vernerey, Dewi; De Mestier, Louis; Lombard-Bohas, Catherine
errShare
errSave
Efficacy and Safety of the Anti-IL1RAP Antibody Nadunolimab (CAN04) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Advanced/Metastatic Pancreatic Cancer
errCLINICAL CANCER RESEARCH
IF10.2
err2024-10-10
err0
errOAAI
errVan Cutsem, Eric; Collignon, Joelle; Eefsen, Rikke L.; Ochsenreither, Sebastian; Zvirbule, Zanete; Ivanauskas, Audrius; Arnold, Dirk; Baltruskeviciene, Edita; Pfeiffer, Per; Yachnin, Jeffrey; Magnusson, Susanne; Millrud, Camilla Rydberg; Sanfridson, Annika; Losic, Nedjad; Garcia-Ribas, Ignacio; Tersago, Dominique; Awada, Ahmad
errShare
errSave
Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2024-09-26
err0
PREAI
errShitara, Kohei; Shah, Manish A.; Lordick, Florian; Van Cutsem, Eric; Ilson, David H.; Klempner, Samuel J.; Kang, Yoon-Koo; Lonardi, Sara; Hung, Yi-Ping; Yamaguchi, Kensei; Enzinger, Peter; Nakajima, Tomoko; Matsangou, Maria; Cao, Ying; Li, Ran; Moran, Diarmuid; Pophale, Rupesh; Oh, Mok; Ranganath, Radhika; Ajani, Jaffer A.; Xu, Rui-Hua
errShare
errSave
Clinical Trial Data Review of the Combination FTD/TPI plus Bevacizumab in the Treatment Landscape of Unresectable Metastatic Colorectal Cancer
errCURRENT TREATMENT OPTIONS IN ONCOLOGY
IF4.7
err2024-09-26
err0
errOAAI
errAndre, Thierry; Van Cutsem, Eric; Taieb, Julien; Fakih, Marwan; Prager, Gerald W.; Ciardiello, Fortunato; Falcone, Alfredo; Saunders, Mark; Amellal, Nadia; Roby, Lucas; Tabernero, Josep; Pfeiffer, Per
errShare
errSave
Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial
errNATURE MEDICINE
IF50
err2024-09-23
err1
errOAAI
errKopetz, Scott; Murphy, Danielle A.; Pu, Jie; Ciardiello, Fortunato; Desai, Jayesh; Van Cutsem, Eric; Wasan, Harpreet Singh; Yoshino, Takayuki; Saffari, Hedieh; Zhang, Xiaosong; Hamilton, Phineas; Xie, Tao; Yaeger, Rona; Tabernero, Josep
errShare
errSave
Treating cancer-associated venous thromboembolism: A practical approach
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2024-09-01
err2
PREAI
errVan Cutsem, Eric; Mahe, Isabelle; Felip, Enriqueta; Agnelli, Giancarlo; Awada, Ahmad; Cohen, Alexander; Falanga, Anna; Mandala, Mario; Peeters, Marc; Tsoukalas, Nikolaos; Verhamme, Peter; Ay, Cihan
errShare
errSave
Encorafenib plus cetuximab (EC) plus FOLFIRI for BRAF V600E-mutant metastatic colorectal cancer (mCRC): Updated results from the BREAKWATER safety lead-in (SLI)
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err1
PREAI
errTabernero, J.; Yoshino, T.; Kim, T. W.; Yaeger, R.; Desai, J.; Wasan, H. S.; Van Cutsem, E.; Ciardiello, F.; Maughan, T.; Eng, C.; Tie, J.; Elez Fernandez, M. E.; Lonardi, S.; Usari, T.; Hahn, E.; Dychter, S.; Ferrier, G.; Zhang, X.; Kopetz, S.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
P
Peter Carmeliet
H-index: 192 · Papers: 1.4K
S
Séverine Vermeire
H-index: 163 · Papers: 2.4K
D
David Cunningham
H-index: 153 · Papers: 2.1K
J
Jaffer A. Ajani
H-index: 152 · Papers: 1.7K
M
Martine Piccart
H-index: 149 · Papers: 1.6K
View more